BOOST Pharma announces successful completion of FDA pre-IND meeting

Full acceptance of proposed clinical development plan.

Preparations started for pivotal Phase III study to be executed in US and Europe.

Successful completion triggers second milestone payment from investors.

Read full press release (PDF)